US4804624A
(en)
*
|
1982-05-21 |
1989-02-14 |
The University Of Tennessee Research Corporation |
Passive agglutination assay for pseudorabies antibody
|
SE8205892D0
(sv)
*
|
1982-10-18 |
1982-10-18 |
Bror Morein |
Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
|
US4772466A
(en)
*
|
1983-08-22 |
1988-09-20 |
Syntex (U.S.A.) Inc. |
Vaccines comprising polyoxypropylene-polyoxyethylene block polymer based adjuvants
|
US4770874A
(en)
*
|
1983-08-22 |
1988-09-13 |
Syntex (U.S.A.) Inc. |
Polyoxypropylene-polyoxyethylene block polymer based adjuvants
|
US5916588A
(en)
*
|
1984-04-12 |
1999-06-29 |
The Liposome Company, Inc. |
Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
|
US6090406A
(en)
*
|
1984-04-12 |
2000-07-18 |
The Liposome Company, Inc. |
Potentiation of immune responses with liposomal adjuvants
|
SE8402861L
(sv)
*
|
1984-05-28 |
1985-11-29 |
Stefan Svenson |
Rening av biologiskt material
|
NL8403195A
(nl)
*
|
1984-10-19 |
1986-05-16 |
Nederlanden Staat |
Immunogene complexen en vaccins die deze bevatten.
|
SE8405493D0
(sv)
*
|
1984-11-01 |
1984-11-01 |
Bror Morein |
Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
|
JPH0832637B2
(ja)
*
|
1985-02-14 |
1996-03-29 |
アクゾ・エヌ・ヴエー |
合成免疫原
|
US4683294A
(en)
*
|
1985-04-03 |
1987-07-28 |
Smith Kline Rit, S.A. |
Process for the extraction and purification of proteins from culture media producing them
|
US4871488A
(en)
*
|
1985-04-22 |
1989-10-03 |
Albany Medical College Of Union University |
Reconstituting viral glycoproteins into large phospholipid vesicles
|
US4631191A
(en)
*
|
1985-06-20 |
1986-12-23 |
Biotechnology Research Partners, Ltd. |
Methods and compositions useful in preventing equine influenza
|
EP0231039B1
(en)
*
|
1986-01-14 |
1992-01-08 |
De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur |
Process for preparing immunological complexes and pharmaceutical composition containing these complexes
|
US4981685A
(en)
*
|
1986-03-07 |
1991-01-01 |
Utah State University Foundation |
Bacterial extract vaccines for veterinary application
|
US4806350A
(en)
*
|
1986-04-18 |
1989-02-21 |
Norden Laboratories, Inc. |
Vaccine formulation
|
CA1331355C
(en)
*
|
1986-04-21 |
1994-08-09 |
Bioenterprises Pty. Ltd |
Immunopotentation
|
ZA872203B
(en)
*
|
1986-04-28 |
1988-02-24 |
New York Blood Center Inc |
Complex immunogen containing synthetic peptides
|
JPH0789951B2
(ja)
*
|
1986-06-18 |
1995-10-04 |
財団法人阪大微生物病研究会 |
遺伝子発現産物の精製法
|
US5374426A
(en)
*
|
1986-09-03 |
1994-12-20 |
University Of Saskatchewan |
Rotavirus nucleocapsid protein VP6 in vaccine compositions
|
US5190859A
(en)
*
|
1987-02-26 |
1993-03-02 |
Dana-Farber Cancer Institute, Inc. |
Purification of LFA-3
|
US5026828A
(en)
*
|
1987-02-27 |
1991-06-25 |
Merck & Co., Inc. |
Method of purifying recombinant pres-1/S-2/S/S hepatitis B antigen from yeast
|
US5976839A
(en)
*
|
1987-03-13 |
1999-11-02 |
Bioenterprises Pty Limited |
Immunopotentiation through covalent linkage between immunogen and immunopotentiating molecules
|
US4888416A
(en)
*
|
1987-03-30 |
1989-12-19 |
International Minerals & Chemical Corp. |
Method for stabilizing somatotropins
|
US5583112A
(en)
*
|
1987-05-29 |
1996-12-10 |
Cambridge Biotech Corporation |
Saponin-antigen conjugates and the use thereof
|
US5043158A
(en)
*
|
1987-08-21 |
1991-08-27 |
Chembiomed, Ltd. |
Immunogenic compositions containing ordered carriers
|
US5011915A
(en)
*
|
1987-10-26 |
1991-04-30 |
Merck & Co., Inc. |
Process for purifying recombinant hepatitis antigens
|
WO1989005151A1
(en)
*
|
1987-12-04 |
1989-06-15 |
The Liposome Company, Inc. |
High integrity liposomes and method of preration and use
|
WO1989006658A1
(en)
*
|
1988-01-13 |
1989-07-27 |
The University Of North Carolina At Chapel Hill |
Immunogenic peptides
|
US5039522A
(en)
*
|
1988-01-29 |
1991-08-13 |
New York Blood Center, Inc. |
Immunogens containing peptides with an attached hydrophobic tail for adsorption to hepatitis B virus surface antigen
|
DK199588D0
(da)
*
|
1988-04-12 |
1988-04-12 |
Nordisk Droge & Kemikalie |
Vaccine
|
US5885589A
(en)
*
|
1988-04-12 |
1999-03-23 |
Intervet International B.V. |
Pasteurella vaccine
|
US5071964A
(en)
*
|
1988-05-04 |
1991-12-10 |
Dana-Farber Cancer Institute, Inc. |
Protein micelles
|
WO1989010938A1
(en)
*
|
1988-05-04 |
1989-11-16 |
Dana-Farber Cancer Institute |
Protein micelles
|
GB8818415D0
(en)
*
|
1988-08-03 |
1988-09-07 |
Animal Health Inst |
Vaccine
|
US6291228B1
(en)
*
|
1988-08-03 |
2001-09-18 |
Vericore Limited |
Vaccine
|
NZ230747A
(en)
*
|
1988-09-30 |
1992-05-26 |
Bror Morein |
Immunomodulating matrix comprising a complex of at least one lipid and at least one saponin; certain glycosylated triterpenoid saponins derived from quillaja saponaria molina
|
JPH0292996A
(ja)
*
|
1988-09-30 |
1990-04-03 |
Bror Morein |
アジュバントおよび脂質を含む複合体
|
US4981684A
(en)
*
|
1989-10-24 |
1991-01-01 |
Coopers Animal Health Limited |
Formation of adjuvant complexes
|
ATE148348T1
(de)
*
|
1989-09-15 |
1997-02-15 |
Tanox Biosystems Inc |
Behandlung von einer autoimmun-krankheit
|
NL9002314A
(nl)
*
|
1990-10-23 |
1992-05-18 |
Nederlanden Staat |
Immunogene complexen, in het bijzonder iscoms.
|
IT1248075B
(it)
*
|
1991-06-18 |
1995-01-05 |
Sclavo Spa |
Processo per la purificazione del virus dell'epatite a (hav), virus cosi` purificato e composizioni vaccinali che lo contengono.
|
GB9200117D0
(en)
*
|
1992-01-06 |
1992-02-26 |
Connaught Lab |
Production of recombinant chimeric proteins for vaccine use
|
DE4220653A1
(de)
*
|
1992-06-26 |
1994-01-13 |
Boehringer Mannheim Gmbh |
Verfahren und Mittel zum Nachweis eines Analyten enthaltend glykosidische Tenside
|
EP0604727A1
(en)
*
|
1992-12-31 |
1994-07-06 |
American Cyanamid Company |
Improved immunogenicity of a vaccine by incorporation of a cytokine within an immune-stimulating complex containing an antigen
|
DE69432417T2
(de)
*
|
1993-09-03 |
2004-02-12 |
Mcgill University, Montreal |
Differentiell exprimierte leishmania gene und proteinen
|
US5773011A
(en)
*
|
1993-09-27 |
1998-06-30 |
Gerbu Biotechnik Gmbh |
Method of preparing a synergistic immunological adjuvant formulation
|
GB9320597D0
(en)
*
|
1993-10-06 |
1993-11-24 |
Proteus Molecular Design |
Improvements in and realting to vaccines
|
US6083513A
(en)
*
|
1993-11-16 |
2000-07-04 |
Gerbu Biotechnik Gmbh |
Method for increasing the yield of antibodies in the techniques of immunology
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
AU4369596A
(en)
*
|
1994-11-21 |
1996-06-17 |
Virginia L. Scofield |
Sperm as vaccine vectors
|
CA2211650A1
(en)
*
|
1995-01-27 |
1996-08-01 |
Genencor International, Inc. |
Surfactant-based extraction process
|
ES2155129T3
(es)
|
1995-06-07 |
2001-05-01 |
Pfizer |
Vacunacion in ovo contra la coccidiosis.
|
SK282436B6
(sk)
*
|
1995-06-07 |
2002-02-05 |
Pfizer Inc. |
Živé sporocysty alebo oocysty Eimeria alebo ich zmesi na výrobu očkovacej látky
|
ZA97452B
(en)
|
1996-01-25 |
1997-08-15 |
Trinity College Dublin |
Streptococcus equi vaccine.
|
GB9618119D0
(en)
*
|
1996-08-30 |
1996-10-09 |
Univ Southampton |
Adjuvants for use in vaccines
|
ZA9710606B
(en)
*
|
1996-12-05 |
1998-06-12 |
Akzo Nobel Nv |
Non-virulent Mycoplasma synoviae vaccine thereof.
|
US6406705B1
(en)
*
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
AUPO732997A0
(en)
*
|
1997-06-12 |
1997-07-03 |
Csl Limited |
Ganglioside immunostimulating complexes and uses thereof
|
US6455323B1
(en)
|
1997-07-03 |
2002-09-24 |
Pharmacia & Upjohn Company |
Anti-bacterial methods and materials
|
US6627205B2
(en)
|
1997-12-01 |
2003-09-30 |
Pfizer Incorporated |
Ovo vaccination against coccidiosis
|
US6495140B1
(en)
|
1998-01-12 |
2002-12-17 |
Her Majesty In Right Of Canada As Represented By The Minister Of Agriculture And Agri-Food Canada |
Process for the isolation, recovery and purification of non-polar extractives
|
US6908770B1
(en)
*
|
1998-07-16 |
2005-06-21 |
Board Of Regents, The University Of Texas System |
Fluid based analysis of multiple analytes by a sensor array
|
US20010033839A1
(en)
*
|
1999-10-04 |
2001-10-25 |
Emilio Barbera-Guillem |
Vaccine and immunotherapy for solid nonlymphoid tumor and related immune dysregulation
|
GB2348203B
(en)
|
1998-11-04 |
2002-06-19 |
Imp College Innovations Ltd |
Solube beta-forms of prion proteins, methods of preparation and use
|
JP5084984B2
(ja)
*
|
1999-02-17 |
2012-11-28 |
シーエスエル、リミテッド |
免疫原複合体およびそれに関する方法
|
US6984378B1
(en)
|
1999-02-26 |
2006-01-10 |
Pfizer, Inc. |
Method for the purification, recovery, and sporulation of cysts and oocysts
|
US6790950B2
(en)
|
1999-04-09 |
2004-09-14 |
Pharmacia & Upjohn Company |
Anti-bacterial vaccine compositions
|
MXPA01010207A
(es)
|
1999-04-09 |
2003-07-21 |
Pharmacia & Upjohn Inc |
Composiciones de vacuna antibacteriana.
|
US6558670B1
(en)
|
1999-04-19 |
2003-05-06 |
Smithkline Beechman Biologicals S.A. |
Vaccine adjuvants
|
DK1187629T3
(da)
|
1999-04-19 |
2005-01-17 |
Glaxosmithkline Biolog Sa |
Adjuvanssammensætning omfattende saponin og et immunostimulerende oligonucleotid
|
EP1214054B1
(en)
*
|
1999-09-24 |
2007-10-31 |
GlaxoSmithKline Biologicals S.A. |
Intranasal influenza virus vaccine
|
NZ518999A
(en)
*
|
1999-11-19 |
2002-12-20 |
Csl Ltd |
Vaccine compositions
|
ATE300949T1
(de)
|
2000-03-17 |
2005-08-15 |
Pharmacia & Upjohn Co Llc |
Ssa inaktivierte salmonella impfstoffe
|
WO2001077365A2
(en)
|
2000-04-06 |
2001-10-18 |
Pharmacia & Upjohn Company |
Antimicrobial methods and materials
|
US7323174B1
(en)
|
2000-06-12 |
2008-01-29 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Modulation of immune response and methods based thereon
|
WO2002032450A2
(en)
*
|
2000-10-18 |
2002-04-25 |
Glaxosmithkline Biologicals S.A. |
Vaccines
|
US20050019340A1
(en)
*
|
2000-10-18 |
2005-01-27 |
Nathalie Garcon |
Vaccines
|
ATE503493T1
(de)
|
2001-02-23 |
2011-04-15 |
Glaxosmithkline Biolog Sa |
Influenza vakzinzusammensetzungen zur intradermaler verabreichung
|
WO2002080981A2
(en)
|
2001-04-04 |
2002-10-17 |
Nordic Vaccine Technology A/S |
Polynucleotide binding complexes comprising sterols and saponins
|
US7713942B2
(en)
*
|
2001-04-04 |
2010-05-11 |
Nordic Vaccine Technology A/S |
Cage-like microparticle complexes comprising sterols and saponins for delivery of polynucleotides
|
GB0109297D0
(en)
|
2001-04-12 |
2001-05-30 |
Glaxosmithkline Biolog Sa |
Vaccine
|
GB0112126D0
(en)
|
2001-05-18 |
2001-07-11 |
Allergene Inc |
Composition
|
US20100221284A1
(en)
|
2001-05-30 |
2010-09-02 |
Saech-Sisches Serumwerk Dresden |
Novel vaccine composition
|
TWI228420B
(en)
|
2001-05-30 |
2005-03-01 |
Smithkline Beecham Pharma Gmbh |
Novel vaccine composition
|
BRPI0211870B1
(pt)
|
2001-08-30 |
2016-01-12 |
Embrex Inc |
método para esporulação de oocistos viáveis de eimeria
|
US20140248273A1
(en)
|
2001-09-08 |
2014-09-04 |
Jos van Strijp |
Vaccine based on staphylococcal superantigen-like 3 protein (ssl3)
|
SE0202110D0
(sv)
|
2002-07-05 |
2002-07-05 |
Isconova Ab |
Iscom preparation and use thereof
|
EP1532253B1
(en)
|
2002-08-12 |
2014-04-30 |
Intervet International BV |
Streptococcus uberis protein, nucleic acid sequence encoding the same and its use in a mastitis vaccine
|
EP1549338B1
(en)
|
2002-10-11 |
2010-12-22 |
Novartis Vaccines and Diagnostics S.r.l. |
Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages
|
US7125425B2
(en)
*
|
2002-10-21 |
2006-10-24 |
Sdgi Holdings, Inc. |
Systems and techniques for restoring and maintaining intervertebral anatomy
|
US7491395B2
(en)
|
2002-11-20 |
2009-02-17 |
Bestewil Holding B.V. |
Compositions comprising antigen-complexes, method of making same as well as methods of using the antigen-complexes for vaccination
|
WO2004045641A2
(en)
|
2002-11-20 |
2004-06-03 |
Crucell Holland B.V. |
Antigen-complexes
|
ES2383175T3
(es)
|
2003-01-30 |
2012-06-18 |
Novartis Ag |
Vacunas inyectables contra múltiples serogrupos de meningococos
|
AR056245A1
(es)
|
2003-06-19 |
2007-10-03 |
Bestewil Holding Bv |
Membranas virales reconstituidas funcionales que contienen un coadyuvante
|
US9023366B2
(en)
|
2003-07-01 |
2015-05-05 |
The Royal Veterinary College |
Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD)
|
GB0315323D0
(en)
|
2003-07-01 |
2003-08-06 |
Royal Veterinary College |
Vaccine composition
|
SE0301998D0
(sv)
|
2003-07-07 |
2003-07-07 |
Isconova Ab |
Quil A fraction with low toxicity and use thereof
|
JP4875490B2
(ja)
|
2003-07-31 |
2012-02-15 |
ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド |
StreptococcusPyogenesについての免疫原組成物
|
CN103357002A
(zh)
|
2003-10-02 |
2013-10-23 |
诺华疫苗和诊断有限公司 |
多种脑膜炎球菌血清群的液体疫苗
|
GB0323103D0
(en)
|
2003-10-02 |
2003-11-05 |
Chiron Srl |
De-acetylated saccharides
|
JP5600375B2
(ja)
|
2004-03-09 |
2014-10-01 |
ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド |
インフルエンザウイルスワクチン
|
GB0500787D0
(en)
|
2005-01-14 |
2005-02-23 |
Chiron Srl |
Integration of meningococcal conjugate vaccination
|
EP2272531A3
(en)
|
2004-04-30 |
2011-04-13 |
Novartis Vaccines and Diagnostics S.r.l. |
Integration of meningococcal conjugate vaccination
|
GB0409745D0
(en)
|
2004-04-30 |
2004-06-09 |
Chiron Srl |
Compositions including unconjugated carrier proteins
|
GB0410866D0
(en)
|
2004-05-14 |
2004-06-16 |
Chiron Srl |
Haemophilius influenzae
|
CA2567446C
(en)
|
2004-05-21 |
2018-01-02 |
Chiron Corporation |
Alphavirus vectors for respiratory pathogen vaccines
|
CA2565500A1
(en)
|
2004-05-28 |
2005-12-15 |
Glaxosmithkline Biologicals S.A. |
Vaccine compositions comprising virosomes and a saponin adjuvant
|
KR100958505B1
(ko)
|
2004-07-18 |
2010-05-17 |
씨에스엘 리미티드 |
면역자극 복합체 및 향상된 인터페론-감마 반응을 유도하기위한 올리고뉴클레오티드 제제
|
US20090317420A1
(en)
|
2004-07-29 |
2009-12-24 |
Chiron Corporation |
Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
|
AU2005294129B2
(en)
|
2004-10-08 |
2010-12-23 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention |
Modulation of replicative fitness by using less frequently used synonymous codons
|
GB0424092D0
(en)
|
2004-10-29 |
2004-12-01 |
Chiron Srl |
Immunogenic bacterial vesicles with outer membrane proteins
|
US8007806B2
(en)
|
2005-01-20 |
2011-08-30 |
Isconova Ab |
Vaccine composition comprising a fibronectin binding protein or a fibronectin binding peptide
|
GB0502095D0
(en)
|
2005-02-01 |
2005-03-09 |
Chiron Srl |
Conjugation of streptococcal capsular saccharides
|
GB0503337D0
(en)
|
2005-02-17 |
2005-03-23 |
Glaxosmithkline Biolog Sa |
Compositions
|
DK1858920T3
(en)
|
2005-02-18 |
2016-02-29 |
Glaxosmithkline Biolog Sa |
PROTEINS AND NUCLEIC ACIDS FROM MENINGITIS / SEPSIS-ASSOCIATED ESCHERICHIA COLI
|
NZ580974A
(en)
|
2005-02-18 |
2011-05-27 |
Novartis Vaccines & Diagnostic |
Immunogens from uropathogenic escherichia coli
|
GB0504436D0
(en)
|
2005-03-03 |
2005-04-06 |
Glaxosmithkline Biolog Sa |
Vaccine
|
EP1896067B1
(en)
|
2005-06-16 |
2011-07-20 |
Universiteit Gent |
Vaccines for immunization against helicobacter
|
EP1912665B1
(en)
|
2005-07-28 |
2011-01-26 |
Pfizer Products Inc. |
Vaccine against feline calicivirus (fcv) comprising a fcv capsid protein or an isolated fcv capsid protein comprising protein sequence seq id no: 13 or protein sequences having at least 95% identity thereto.
|
GB0519871D0
(en)
|
2005-09-30 |
2005-11-09 |
Secr Defence |
Immunogenic agents
|
KR20080042174A
(ko)
|
2005-10-07 |
2008-05-14 |
화이자 프로덕츠 인코포레이티드 |
개과 동물의 인플루엔자의 치료를 위한 백신 및 방법
|
CN101355960A
(zh)
|
2005-10-18 |
2009-01-28 |
诺华疫苗和诊断公司 |
使用α病毒复制子颗粒进行粘膜和全身免疫
|
CA2628152C
(en)
|
2005-11-04 |
2016-02-02 |
Novartis Vaccines And Diagnostics S.R.L. |
Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
|
US7527801B2
(en)
|
2005-11-22 |
2009-05-05 |
Novartis Vaccines And Diagnostics, Inc. |
Norovirus and Sapovirus antigens
|
GB0524066D0
(en)
|
2005-11-25 |
2006-01-04 |
Chiron Srl |
741 ii
|
GB0607088D0
(en)
|
2006-04-07 |
2006-05-17 |
Glaxosmithkline Biolog Sa |
Vaccine
|
CA2633772C
(en)
|
2005-12-22 |
2015-09-15 |
Ralph Leon Biemans |
Pneumococcal polysaccharide conjugate vaccine
|
WO2007085969A2
(en)
|
2006-01-27 |
2007-08-02 |
Novartis Vaccines And Diagnostics Gmbh & Co Kg |
Influenza vaccines containing hemagglutinin and matrix proteins
|
US8063063B2
(en)
|
2006-03-23 |
2011-11-22 |
Novartis Ag |
Immunopotentiating compounds
|
EP2357184B1
(en)
|
2006-03-23 |
2015-02-25 |
Novartis AG |
Imidazoquinoxaline compounds as immunomodulators
|
CN101448523A
(zh)
|
2006-03-24 |
2009-06-03 |
诺华疫苗和诊断有限两合公司 |
无需冷藏储存流感疫苗
|
EP1998802A2
(en)
|
2006-03-30 |
2008-12-10 |
GlaxoSmithKline Biologicals S.A. |
Immunogenic composition
|
CA2647942A1
(en)
|
2006-03-31 |
2007-11-08 |
Novartis Ag |
Combined mucosal and parenteral immunization against hiv
|
US20100015168A1
(en)
|
2006-06-09 |
2010-01-21 |
Novartis Ag |
Immunogenic compositions for streptococcus agalactiae
|
EP2044104A2
(en)
|
2006-06-29 |
2009-04-08 |
Novartis AG |
Polypeptides from neisseria meningitidis
|
KR20090094213A
(ko)
|
2006-07-18 |
2009-09-04 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
말라리아 백신
|
GB0614460D0
(en)
|
2006-07-20 |
2006-08-30 |
Novartis Ag |
Vaccines
|
GB2453475B
(en)
|
2006-07-25 |
2011-01-19 |
Secr Defence |
Live vaccine strain
|
AU2007285484B2
(en)
|
2006-08-16 |
2013-05-02 |
Novartis Ag |
Immunogens from uropathogenic Escherichia coli
|
CA3016948A1
(en)
|
2006-09-11 |
2008-03-20 |
Seqirus UK Limited |
Making influenza virus vaccines without using eggs
|
HUE036180T2
(hu)
|
2006-09-26 |
2018-06-28 |
Infectious Disease Res Inst |
Szintetikus adjuvánst tartalmazó vakcina készítmény
|
US20090181078A1
(en)
|
2006-09-26 |
2009-07-16 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
PT2121011E
(pt)
|
2006-12-06 |
2014-07-31 |
Novartis Ag |
Vacinas compreendendo um antigénio a partir de quatro estirpes do vírus da gripe
|
MX2009007087A
(es)
|
2006-12-27 |
2009-08-12 |
Pfizer Prod Inc |
Metodos para la administracion de vacunas.
|
GB0700562D0
(en)
|
2007-01-11 |
2007-02-21 |
Novartis Vaccines & Diagnostic |
Modified Saccharides
|
WO2008146164A2
(en)
|
2007-05-25 |
2008-12-04 |
Novartis Ag |
Streptococcus pneumoniae pilus antigens
|
BRPI0813307C1
(pt)
|
2007-06-26 |
2021-05-25 |
Glaxosmithkline Biologicals Sa |
composição imunogênica, vacina, e, processo para fabricar a vacina
|
PT2185191E
(pt)
|
2007-06-27 |
2012-11-27 |
Novartis Ag |
Vacinas contra a gripe com baixo teor de aditivos
|
GB0713880D0
(en)
|
2007-07-17 |
2007-08-29 |
Novartis Ag |
Conjugate purification
|
GB0714963D0
(en)
|
2007-08-01 |
2007-09-12 |
Novartis Ag |
Compositions comprising antigens
|
CA2699513C
(en)
|
2007-09-12 |
2018-03-13 |
Novartis Ag |
Gas57 mutant antigens and gas57 antibodies
|
EP2062594A1
(en)
|
2007-11-21 |
2009-05-27 |
Wyeth Farma, S.A. |
Bluetongue virus vaccine and immunogenic compositions, methods of use and methods of producing same
|
GB0810305D0
(en)
|
2008-06-05 |
2008-07-09 |
Novartis Ag |
Influenza vaccination
|
AU2008352942B2
(en)
|
2007-12-19 |
2013-09-12 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. |
Soluble forms of Hendra and Nipah virus F glycoprotein and uses thereof
|
GB0818453D0
(en)
|
2008-10-08 |
2008-11-12 |
Novartis Ag |
Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
|
EP2537857B1
(en)
|
2007-12-21 |
2017-01-18 |
GlaxoSmithKline Biologicals SA |
Mutant forms of streptolysin O
|
JP5711972B2
(ja)
|
2007-12-24 |
2015-05-07 |
アイディー バイオメディカル コーポレイション オブ ケベック |
組換えrsv抗原
|
AU2009215364B2
(en)
|
2008-02-21 |
2014-09-18 |
Glaxosmithkline Biologicals S.A. |
Meningococcal fHBP polypeptides
|
EP2889042A3
(en)
|
2008-03-18 |
2015-10-14 |
Novartis AG |
Improvements in preparation of influenza virus vaccine antigens
|
US8585505B2
(en)
|
2008-12-15 |
2013-11-19 |
Tetris Online, Inc. |
Inter-game interactive hybrid asynchronous computer game infrastructure
|
AU2010204139A1
(en)
|
2009-01-12 |
2011-08-11 |
Novartis Ag |
Cna_B domain antigens in vaccines against gram positive bacteria
|
GB0900455D0
(en)
|
2009-01-13 |
2009-02-11 |
Secr Defence |
Vaccine
|
GB0901423D0
(en)
|
2009-01-29 |
2009-03-11 |
Secr Defence |
Treatment
|
GB0901411D0
(en)
|
2009-01-29 |
2009-03-11 |
Secr Defence |
Treatment
|
KR101738704B1
(ko)
|
2009-02-17 |
2017-06-08 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
알루미늄-비함유 아주반트를 포함하는 불활성화 뎅기 바이러스 백신
|
CN102438650A
(zh)
|
2009-03-06 |
2012-05-02 |
诺华有限公司 |
衣原体抗原
|
GB0906234D0
(en)
|
2009-04-14 |
2009-05-20 |
Secr Defence |
Vaccine
|
SG175092A1
(en)
|
2009-04-14 |
2011-11-28 |
Novartis Ag |
Compositions for immunising against staphylococcus aerus
|
TWI549688B
(zh)
|
2009-06-05 |
2016-09-21 |
美國疾病傳染研究機構 |
合成的葡萄吡喃糖基脂質佐劑
|
EP2944320A1
(en)
|
2009-06-15 |
2015-11-18 |
National University of Singapore |
Influenza vaccine, composition, and methods of use
|
EP2445527A2
(en)
|
2009-06-24 |
2012-05-02 |
ID Biomedical Corporation of Quebec |
Vaccine
|
DK2445526T3
(en)
|
2009-06-24 |
2016-06-27 |
Glaxosmithkline Biologicals Sa |
Recombinant RSV antigens.
|
WO2011005183A1
(en)
*
|
2009-07-10 |
2011-01-13 |
Isconova Ab |
New composition
|
CN102639147B
(zh)
|
2009-07-15 |
2015-11-25 |
诺华股份有限公司 |
Rsv f 蛋白组合物和其制作方法
|
ES2670799T3
(es)
|
2009-07-16 |
2018-06-01 |
Glaxosmithkline Biologicals Sa |
Inmunógenos desintoxicados de Escherichia coli
|
GB0913680D0
(en)
|
2009-08-05 |
2009-09-16 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
EP3017828A1
(en)
|
2009-08-27 |
2016-05-11 |
GlaxoSmithKline Biologicals SA |
Hybrid polypeptides including meningococcal fhbp sequences
|
US20110110980A1
(en)
|
2009-09-02 |
2011-05-12 |
Wyeth Llc |
Heterlogous prime-boost immunization regimen
|
CN102695523A
(zh)
|
2009-09-10 |
2012-09-26 |
诺华有限公司 |
针对呼吸道疾病的组合疫苗
|
GB0917002D0
(en)
|
2009-09-28 |
2009-11-11 |
Novartis Vaccines Inst For Global Health Srl |
Improved shigella blebs
|
GB0917003D0
(en)
|
2009-09-28 |
2009-11-11 |
Novartis Vaccines Inst For Global Health Srl |
Purification of bacterial vesicles
|
US8974799B2
(en)
|
2009-09-30 |
2015-03-10 |
Novartis Ag |
Conjugation of Staphylococcus aureus type 5 and type 8 capsular polysaccharides
|
CN102724988B
(zh)
|
2009-09-30 |
2014-09-10 |
诺华股份有限公司 |
脑膜炎球菌fHBP多肽的表达
|
CN107648600A
(zh)
|
2009-10-19 |
2018-02-02 |
英特维特国际股份有限公司 |
链球菌组合疫苗
|
GB0918392D0
(en)
|
2009-10-20 |
2009-12-02 |
Novartis Ag |
Diagnostic and therapeutic methods
|
MX2012004594A
(es)
|
2009-10-22 |
2012-09-07 |
Univ Leipzig |
Deteccion de un circovirus en terneros que padecen de pancitopenia neonatal bovina.
|
WO2011051893A1
(en)
|
2009-10-27 |
2011-05-05 |
Novartis Ag |
Modified meningococcal fhbp polypeptides
|
GB0919690D0
(en)
|
2009-11-10 |
2009-12-23 |
Guy S And St Thomas S Nhs Foun |
compositions for immunising against staphylococcus aureus
|
GB201003333D0
(en)
|
2010-02-26 |
2010-04-14 |
Novartis Ag |
Immunogenic proteins and compositions
|
JP2013523617A
(ja)
|
2010-03-26 |
2013-06-17 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
Hivワクチン
|
GB201005625D0
(en)
|
2010-04-01 |
2010-05-19 |
Novartis Ag |
Immunogenic proteins and compositions
|
US9597326B2
(en)
|
2010-04-13 |
2017-03-21 |
Glaxosmithkline Biologicals Sa |
Benzonapthyridine compositions and uses thereof
|
CA2796178C
(en)
|
2010-04-21 |
2021-02-16 |
Pharmaq As |
Nucleic acid sequences of fish cardiomyopathy syndrome virus and the use thereof
|
EP3705133B1
(en)
|
2010-05-14 |
2024-06-26 |
Baxalta Incorporated |
Ospa chimeras and use thereof in vaccines
|
US9238796B2
(en)
|
2010-06-04 |
2016-01-19 |
Toagosei Co. Ltd. |
Cell growth-promoting peptide and use thereof
|
GB201009861D0
(en)
|
2010-06-11 |
2010-07-21 |
Novartis Ag |
OMV vaccines
|
JP5894154B2
(ja)
|
2010-06-24 |
2016-03-23 |
ジェネンテック, インコーポレイテッド |
タンパク質含有製剤の安定化のためのアルキルグリコシドを含む組成物及び方法
|
US9192661B2
(en)
|
2010-07-06 |
2015-11-24 |
Novartis Ag |
Delivery of self-replicating RNA using biodegradable polymer particles
|
WO2012010290A1
(en)
|
2010-07-21 |
2012-01-26 |
Athera Biotechnologies Ab |
Diagnostic and therapeutic methods and compositions for metabolic disease
|
WO2012010291A1
(en)
|
2010-07-21 |
2012-01-26 |
Athera Biotechnologies Ab |
Diagnostic and therapeutic methods and compositions for metabolic disease
|
BR112013001514A2
(pt)
|
2010-07-23 |
2016-06-07 |
Erasmus University Rotterdam Medical Ct |
vacina para influenza
|
US8628947B2
(en)
|
2010-08-30 |
2014-01-14 |
Intervet Inc. |
Potomac horse fever isolates
|
GB201101665D0
(en)
|
2011-01-31 |
2011-03-16 |
Novartis Ag |
Immunogenic compositions
|
KR20130139953A
(ko)
|
2010-09-27 |
2013-12-23 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
백신
|
GB201017519D0
(en)
|
2010-10-15 |
2010-12-01 |
Novartis Vaccines Inst For Global Health S R L |
Vaccines
|
WO2012059593A1
(en)
|
2010-11-05 |
2012-05-10 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Vaccines for preventing meningococcal infections
|
EP2640832B1
(en)
|
2010-11-15 |
2017-12-20 |
Pharmaq AS |
New ethiological agent
|
WO2012072769A1
(en)
|
2010-12-01 |
2012-06-07 |
Novartis Ag |
Pneumococcal rrgb epitopes and clade combinations
|
EP2462950A1
(en)
|
2010-12-08 |
2012-06-13 |
Neovacs |
Strongly inactivated and still highly immunogenic vaccine, and process of manufacturing thereof
|
CA2820837A1
(en)
|
2010-12-08 |
2012-06-14 |
Neovacs |
Strongly inactivated and still highly immunogenic vaccine and process of manufacturing thereof
|
GB201022007D0
(en)
|
2010-12-24 |
2011-02-02 |
Imp Innovations Ltd |
DNA-sensor
|
US20130315959A1
(en)
|
2010-12-24 |
2013-11-28 |
Novartis Ag |
Compounds
|
US9139618B2
(en)
|
2010-12-29 |
2015-09-22 |
Intervet Inc. |
Salmonid alphavirus protein E2
|
RU2599544C2
(ru)
|
2010-12-29 |
2016-10-10 |
Интервет Интернэшнл Б.В. |
Вакцинный антиген бабезиоза собак
|
US9506933B2
(en)
|
2011-01-07 |
2016-11-29 |
Toagosei Co., Ltd. |
Method of preparing antigen for acquiring anti-hydrophobic peptide antibody
|
HUE043879T2
(hu)
|
2011-01-26 |
2019-09-30 |
Glaxosmithkline Biologicals Sa |
RSV-immunizálási rend
|
WO2012131099A1
(en)
|
2011-03-31 |
2012-10-04 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Use of blood or tissue bacteriome for prediction, diagnosis and prevention of metabolic diseases and their cardiovascular complications
|
KR102017905B1
(ko)
|
2011-04-07 |
2019-09-03 |
니오베크스 |
Ifn 알파 관련 질환을 치료하는 방법
|
EP2508197A1
(en)
|
2011-04-07 |
2012-10-10 |
Neovacs |
Method for treating IFNalpha related conditions
|
RU2681529C2
(ru)
|
2011-05-13 |
2019-03-07 |
Генри М. Джексон Фаундейшн Фор Дзе Эдвансмент Оф Милитари Медсин, Инк. |
Иммуногенные композиции гликопротеина g вирусов hendra и nipah
|
RS56748B1
(sr)
|
2011-05-13 |
2018-03-30 |
Glaxosmithkline Biologicals Sa |
Pre-fuzioni rsv f antigeni
|
US11896636B2
(en)
|
2011-07-06 |
2024-02-13 |
Glaxosmithkline Biologicals Sa |
Immunogenic combination compositions and uses thereof
|
WO2013006842A2
(en)
|
2011-07-06 |
2013-01-10 |
Novartis Ag |
Immunogenic compositions and uses thereof
|
US9149541B2
(en)
|
2011-07-08 |
2015-10-06 |
Novartis Ag |
Tyrosine ligation process
|
TR201909110T4
(tr)
|
2011-09-14 |
2019-07-22 |
Glaxosmithkline Biologicals Sa |
Sakarit-protein glikokonjugatları yapmaya yönelik yöntemler.
|
JP6050822B2
(ja)
|
2011-10-03 |
2016-12-21 |
モレインクス,エービー |
ナノ粒子、ナノ粒子の調製のための処理、および癌治療および食品関連化合物を含む医療分野における両親媒性分子または疎水性分子ための担体としてのナノ粒子の使用
|
JP6170932B2
(ja)
|
2011-11-07 |
2017-07-26 |
ノバルティス アーゲー |
spr0096抗原およびspr2021抗原を含むキャリア分子
|
EP2782598B1
(en)
|
2011-11-23 |
2020-05-27 |
In3Bio Ltd. |
Recombinant proteins and their therapeutic uses
|
US9089574B2
(en)
|
2011-11-30 |
2015-07-28 |
Emory University |
Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections
|
GB201200259D0
(en)
|
2012-01-09 |
2012-02-22 |
Ohlin Per M |
Novel therapies
|
WO2013108272A2
(en)
|
2012-01-20 |
2013-07-25 |
International Centre For Genetic Engineering And Biotechnology |
Blood stage malaria vaccine
|
PT2811981T
(pt)
|
2012-02-07 |
2019-06-12 |
Infectious Disease Res Inst |
Formulações adjuvantes melhoradas que compreendem os agonistas de tlr4 e os seus métodos de utilização
|
PT2850431T
(pt)
|
2012-05-16 |
2018-07-23 |
Immune Design Corp |
Vacinas para hsv-2
|
US10124051B2
(en)
|
2012-05-22 |
2018-11-13 |
Glaxosmithkline Biologicals Sa |
Meningococcus serogroup X conjugate
|
US9370182B2
(en)
|
2012-05-28 |
2016-06-21 |
Toagosei Co., Ltd. |
Antimicrobial peptide and use thereof
|
JP2015522580A
(ja)
|
2012-07-06 |
2015-08-06 |
ノバルティス アーゲー |
免疫学的組成物およびその使用
|
KR20150038380A
(ko)
|
2012-07-27 |
2015-04-08 |
백스터 인터내셔널 인코포레이티드 |
키메라 ospa 분자를 포함하는 조성물 및 이의 사용 방법
|
US20140037680A1
(en)
|
2012-08-06 |
2014-02-06 |
Glaxosmithkline Biologicals, S.A. |
Novel method
|
SG11201500573RA
(en)
|
2012-08-06 |
2015-02-27 |
Glaxosmithkline Biolog Sa |
Method for eliciting in infants an immune response against rsv and b. pertussis
|
WO2014043189A1
(en)
|
2012-09-14 |
2014-03-20 |
The Regents Of The University Of Colorado, A Body Corporate |
Conditionally replication deficient herpes viruses and use thereof in vaccines
|
AU2013320313B2
(en)
|
2012-09-18 |
2018-07-12 |
Glaxosmithkline Biologicals Sa |
Outer membrane vesicles
|
WO2014053607A1
(en)
|
2012-10-03 |
2014-04-10 |
Novartis Ag |
Immunogenic compositions
|
WO2014061749A1
(ja)
|
2012-10-18 |
2014-04-24 |
東亞合成株式会社 |
2型tnf受容体の発現を抑制する合成ペプチド及びその利用
|
RU2018137673A
(ru)
|
2012-11-30 |
2019-03-22 |
Глаксосмитклайн Байолоджикалс Са |
Антигены и комбинации антигенов pseudomonas
|
AR095425A1
(es)
|
2013-03-15 |
2015-10-14 |
Glaxosmithkline Biologicals Sa |
Vacuna, uso y procedimiento para prevenir una infección por picornavirus
|
KR102391734B1
(ko)
|
2013-03-15 |
2022-04-29 |
인3바이오 리미티드 |
자기조립형 합성 단백질
|
NZ712410A
(en)
|
2013-03-26 |
2020-01-31 |
The Pirbright Inst |
Stabilised fmdv capsids
|
AR095962A1
(es)
|
2013-04-01 |
2015-11-25 |
Moreinx Ab |
Nanopartículas, compuestas de esterol y saponina de quillaja saponaria molina, proceso para preparación y uso de las mismas como portadores para moléculas anfipáticas o hidrófobas en el campo de la medicina incluyendo tratamiento de cáncer y compuestos relacionados con alimentos
|
EP3711768A1
(en)
|
2013-04-18 |
2020-09-23 |
Immune Design Corp. |
Gla monotherapy for use in cancer treatment
|
US9463198B2
(en)
|
2013-06-04 |
2016-10-11 |
Infectious Disease Research Institute |
Compositions and methods for reducing or preventing metastasis
|
EA201690115A1
(ru)
|
2013-08-05 |
2016-07-29 |
Глаксосмитклайн Байолоджикалс С.А. |
Комбинированные иммуногенные композиции
|
EP3552621A3
(en)
|
2013-10-11 |
2020-01-08 |
Servizo Galego De Saúde (Sergas) |
Live attenuated vaccines
|
EP2870974A1
(en)
|
2013-11-08 |
2015-05-13 |
Novartis AG |
Salmonella conjugate vaccines
|
MX2016007870A
(es)
|
2013-12-16 |
2016-10-07 |
Zoetis Services Llc |
Composiciones inmunogenas de glucoproteina g de los virus hendra y nipah.
|
US11801223B2
(en)
|
2013-12-31 |
2023-10-31 |
Access To Advanced Health Institute |
Single vial vaccine formulations
|
PT3122378T
(pt)
|
2014-03-26 |
2020-03-04 |
Glaxosmithkline Biologicals Sa |
Antigénios estafilocócicos mutantes
|
US10813984B2
(en)
|
2014-04-24 |
2020-10-27 |
Rhode Island Hospital |
Aspartate-β-hydroxylase induces epitope-specific T cell responses in tumors
|
MX2016016533A
(es)
|
2014-06-13 |
2017-05-01 |
Glaxosmithkline Biologicals Sa |
Combinaciones inmunogenas.
|
WO2016011324A2
(en)
|
2014-07-18 |
2016-01-21 |
Oregon Health & Science University |
5'-triphosphate oligoribonucleotides
|
JP6820830B2
(ja)
|
2014-07-18 |
2021-01-27 |
ユニヴァーシティ オブ ワシントン |
がんワクチン組成物およびその使用方法
|
CN104250640A
(zh)
|
2014-08-22 |
2014-12-31 |
普莱柯生物工程股份有限公司 |
猪伪狂犬病病毒基因缺失株、疫苗组合物及其制备方法和应用
|
ES2788393T3
(es)
|
2014-09-03 |
2020-10-21 |
Intervet Int Bv |
Coronavirus de bovino atenuado y vacunas relacionadas
|
WO2016050961A1
(en)
|
2014-10-03 |
2016-04-07 |
Intervet International B.V. |
Broad-spectrum vaccine against avian reovirus
|
CN107001449A
(zh)
|
2014-10-15 |
2017-08-01 |
芝诺锡拉公司 |
具有降低的免疫原性的组合物
|
AU2015384786B2
(en)
|
2015-03-03 |
2020-08-27 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Display platform from bacterial spore coat proteins
|
CN105087506B
(zh)
|
2015-03-20 |
2020-06-30 |
普莱柯生物工程股份有限公司 |
一种猪伪狂犬病病毒致弱方法、及其致弱的病毒株、疫苗组合物和应用
|
JP6886410B2
(ja)
|
2015-06-10 |
2021-06-16 |
ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
核酸含有組成物の作製および精製のためのプロセス
|
CA2996007A1
(en)
|
2015-09-03 |
2017-03-09 |
Novavax, Inc. |
Vaccine compositions having improved stability and immunogenicity
|
CN105770887A
(zh)
*
|
2016-03-04 |
2016-07-20 |
邓招红 |
一种用于hbv疫苗的佐剂及其制备方法
|
GB2551984B
(en)
|
2016-06-30 |
2019-01-16 |
Pharmaq As |
Fish virus
|
CA3153265A1
(en)
|
2016-08-17 |
2018-02-22 |
Pharmaq As |
Sea lice vaccine
|
GB201614799D0
(en)
|
2016-09-01 |
2016-10-19 |
Glaxosmithkline Biologicals Sa |
Compositions
|
CA3043790A1
(en)
|
2016-12-16 |
2018-06-21 |
Institute For Research In Biomedicine |
Novel recombinant prefusion rsv f proteins and uses thereof
|
JP2020527579A
(ja)
|
2017-07-18 |
2020-09-10 |
イン3バイオ・リミテッドIn3Bio Ltd. |
合成タンパク質およびその治療学的用途
|
JP7339942B2
(ja)
|
2017-09-08 |
2023-09-06 |
アクセス ツー アドバンスト ヘルス インスティチュート |
サポニンを含むリポソーム製剤および使用方法
|
CA3092984A1
(en)
|
2018-03-19 |
2019-09-26 |
Novavax, Inc. |
Multivalent influenza nanoparticle vaccines
|
EP3581201A1
(en)
|
2018-06-15 |
2019-12-18 |
GlaxoSmithKline Biologicals S.A. |
Escherichia coli o157:h7 proteins and uses thereof
|
JP2021534761A
(ja)
|
2018-08-23 |
2021-12-16 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
免疫原性タンパク質および組成物
|
CN114340665A
(zh)
|
2019-05-25 |
2022-04-12 |
传染病研究所 |
用于对佐剂疫苗乳剂进行喷雾干燥的组合物和方法
|
CN114269792A
(zh)
|
2019-06-25 |
2022-04-01 |
因斯瑞拜奥有限公司 |
稳定的嵌合合成蛋白及其治疗用途
|
WO2021097347A1
(en)
|
2019-11-15 |
2021-05-20 |
Infectious Disease Research Institute |
Rig-i agonist and adjuvant formulation for tumor treatment
|
US10953089B1
(en)
|
2020-01-27 |
2021-03-23 |
Novavax, Inc. |
Coronavirus vaccine formulations
|
EP3922255A1
(en)
|
2020-06-10 |
2021-12-15 |
Prokarium Limited |
Cancer therapy
|
IL303334A
(en)
|
2020-12-02 |
2023-07-01 |
Glaxosmithkline Biologicals Sa |
The perfect fimh by a donor strand
|
CA3203043A1
(en)
|
2020-12-23 |
2022-06-30 |
Odile DUVAUX |
Composition of pig polyclonal antibody for its use to treat and/or prevent antibody-dependent macrophage pro-inflammatory cytokine release in a passive anti-infectious immunotherap
|
EP4124342A1
(en)
|
2021-07-28 |
2023-02-01 |
Prokarium Limited |
Cancer therapy with live attenuated bacteria
|
WO2023079528A1
(en)
|
2021-11-05 |
2023-05-11 |
King Abdullah University Of Science And Technology |
Compositions suitable for use in a method for eliciting cross-protective immunity against coronaviruses
|
WO2023114727A1
(en)
|
2021-12-13 |
2023-06-22 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Bacteriophage lambda-vaccine system
|
GB2622559A
(en)
|
2022-05-10 |
2024-03-27 |
Johan Frostegaard |
Compositions, methods and uses
|
WO2023225458A1
(en)
|
2022-05-16 |
2023-11-23 |
Zoetis Services Llc |
Vaccines against moritella viscosa
|
GB202209588D0
(en)
|
2022-06-29 |
2022-08-10 |
Plant Bioscience Ltd |
Methods and compositions
|
GB202215134D0
(en)
|
2022-10-13 |
2022-11-30 |
Prokarium Ltd |
Composition
|
GB202215576D0
(en)
|
2022-10-21 |
2022-12-07 |
Prokarium Ltd |
Circuit
|
WO2024130009A1
(en)
|
2022-12-14 |
2024-06-20 |
Yale University |
Compositions and methods of use thereof for the treatment of virally driven cancers
|